Consolidated Statements of Operations and Comprehensive Income (Loss) | ||||||||
(Unaudited) | ||||||||
For the six months ended June 30, | ||||||||
2023 |
2024
| |||||||
RMB | RMB | US$ | ||||||
Net revenues | 52,268,716 | 24,739,480 | 3,471,331 | |||||
Cost of revenues | 115,167,091 | 24,709,417 | 3,467,112 | |||||
Gross profit (loss) | (62,898,375 | ) | 30,063 | 4,219 | ||||
Operating expenses: | ||||||||
Selling and marketing expenses | 9,501,537 | 4,334,564 | 608,206 | |||||
General and administrative expenses | 31,041,335 | 25,453,212 | 3,571,478 | |||||
Research and development expenses | 32,953,337 | 28,934,228 | 4,059,919 | |||||
Total operating expenses | 73,496,209 | 58,722,004 | 8,239,603 | |||||
Loss from operations | (136,394,584 | ) | (58,691,941 | ) | (8,235,384 | ) | ||
Other expenses (income): | ||||||||
Finance expenses (income) | 1,600,591 | (607,804 | ) | (85,284 | ) | |||
Interest expenses | - | 2,009,586 | 281,976 | |||||
Interest income | (335,986 | ) | (96,679 | ) | (13,566 | ) | ||
Other income | (3,339,708 | ) | (851,374 | ) | (119,461 | ) | ||
Total other expenses (income) | (2,075,103 | ) | 453,729 | 63,665 | ||||
Loss before income tax provision | (134,319,481 | ) | (59,145,670 | ) | (8,299,049 | ) | ||
Income tax provision | - | - | - | |||||
Net loss | (134,319,481 | ) | (59,145,670 | ) | (8,299,049 | ) | ||
Less: net loss attributable to noncontrolling interests | - | (1,911,930 | ) | (268,273 | ) | |||
Net loss attributable to Nano Labs Ltd | (134,319,481 | ) | (57,233,740 | ) | (8,030,776 | ) | ||
Comprehensive income (loss): | ||||||||
Net loss | (134,319,481 | ) | (59,145,670 | ) | (8,299,049 | ) | ||
Other comprehensive income: | ||||||||
Foreign currency translation adjustment | 1,771,255 | 4,800,723 | 673,616 | |||||
Total comprehensive loss | (132,548,226 | ) | (54,344,947 | ) | (7,625,433 | ) | ||
Comprehensive loss attributable to noncontrolling interests | - | (1,912,013 | ) | (268,285 | ) | |||
Comprehensive loss attributable to Nano Labs Ltd | (132,548,226 | ) | (52,432,934 | ) | (7,357,148 | ) | ||
Net loss per ordinary share attributable to Nano Labs Ltd | ||||||||
Basic* | (2.41 | ) | (0.85 | ) | (0.12 | ) | ||
Diluted* | (2.41 | ) | (0.85 | ) | (0.12 | ) | ||
Weighted average number of shares used in per share calculation: | ||||||||
Basic* | 55,748,336 | 67,666,712 | 67,666,712 | |||||
Diluted* | 55,748,336 | 67,666,712 | 67,666,712 | |||||